BRAINTREE - Haemonetics Corp. said its profit grew 22 percent in the fiscal second quarter.
The maker of blood collection and processing systems said its profit rose to $18.1 million, or 69 cents per share. That compares with $14.8 million, or 57 cents, a year earlier. Revenue increased 8 percent to $157.1 million, from $145.9 million.
Analysts were expecting 65 cents per share and $157.8 million in revenue, according to a Thomson Reuters survey.
In the three months ended Sept. 26, Haemonetics said plasma disposables revenue climbed 19 percent to $59 million, and platelet disposables revenue rose 3 percent to $37 million. Red cell disposables revenue fell 2 percent to $11 million, and software solutions revenue rose 29 percent to $9 million.
For the full year, the company maintained its profit forecast of $2.75 to $2.85 per share, with revenue growth of 8 to 11 percent.
Haemonetics reported $598 million in revenue in fiscal 2009, so the outlook implies $645.8 million to $663.8 million in revenue.
Analysts expect a profit of $2.81 per share and revenue of $654 million in fiscal 2010.
